Building Clinical Confidence: Evidence-based Care for People Living with MS: Module 3. Managing progressive disease is organized by Catamount Medical Education, Consortium of Multiple Sclerosis Centers (CMSC).
Released On: April 26, 2023
Expires On: April 26, 2024
Learning Objectives
At the conclusion of this activity, participants should be better able to:
• Review the mechanism of action for current and emerging therapies for the treatment of progressive MS
• Discuss efficacy and safety data from recent clinical trials for treatment for progressive MS
Additional details will be posted as soon as information is available.
Accreditation
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The CMSC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for a maximum of 1.00 NCPD credit (1.00 in the area of pharmacology).
Pharmacists
This knowledge-based activity, UAN: JA4008165-9999-23-012-H01-P, qualifies for 1.00 contact hours (0.10 CEUs) of continuing pharmacy education credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved